iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News

ETF Overview

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors.

Key Stats

• Today's Range: $63.58 to $64.83
• 50-Day Range: $61.00 to $70.94
• 52-Week Range: $58.97 to $73.28
• Volume: 100,228 shs
• Average Volume: 70,177 shs
• Market Capitalization: $557.54 million
• Assets Under Management: $560.62 million
• Dividend Yield: 1.79%
• Net Expense Ratio: 0.40%
• Aggregate Rating: Moderate Buy

IHE ETF - Frequently Asked Questions

How have IHE shares performed this year?

iShares U.S. Pharmaceuticals ETF's stock was trading at $65.72 at the beginning of the year. Since then, IHE stock has decreased by 1.4% and is now trading at $64.83.
View the best growth stocks for 2025 here.

When did iShares U.S. Pharmaceuticals ETF's stock split?

iShares U.S. Pharmaceuticals ETF's stock split before market open on Thursday, March 7th 2024. The 3-1 split was announced on Thursday, March 7th 2024. The newly minted shares were payable to shareholders after the market closes on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Who are iShares U.S. Pharmaceuticals ETF's major shareholders?

Top institutional shareholders of iShares U.S. Pharmaceuticals ETF include LPL Financial LLC (1.39%), Goldman Sachs Group Inc. (1.22%), Royal Bank of Canada (1.19%) and Brown Advisory Inc. (1.06%).

How do I buy shares of iShares U.S. Pharmaceuticals ETF?

Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of iShares U.S. Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares U.S. Pharmaceuticals ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), Visa (V), Adobe (ADBE), Lam Research (LRCX) and Advanced Micro Devices (AMD).

Fund Details

• Issuer: iShares
• Fund Name: iShares U.S. Pharmaceuticals ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:IHE
• Inception Date: 5/1/2006
• Fund Manager: Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
• Web: www.iShares.com
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: Dow Jones U.S. Select Pharmaceuticals Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 41

Fund Statistics

• Assets Under Management: $560.62 million
• Average Daily Volume: $130,866.90
• Discount/Premium: 0.02%

Administrator, Advisor and Custodian

• Administrator: Citibank, N.A.
• Advisor: BlackRock Fund Advisors
• Custodian: Citibank, N.A.
• Distributor: BlackRock Investments, LLC
• Transfer Agent: Citibank, N.A.
• Trustee: N/A
• Lead Market Maker: Latour Trading

Options

• Optionable: Optionable
• Options Volume: 7
• Put Options: 7
• Call Options: 2
• Short Interest: 481,700 shs

Miscellaneous

• Outstanding Shares: 8,600,000
• Beta: 0.63
• Creation Unit: 50,000
• Creation Fee: $306.00